Global Single Cell RNA Kit Market Value Is Forecast To Reach By 2034 With CAGR

Single Cell RNA Kit by Type (Isolation Kit, Purification Kit, Library Preparation Kit, Other), by Application (Science and Research, Biomedical Science, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $980 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $980 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Single Cell RNA Kit Market Size | CAGR 15.2 Forecast 2033

Global Single Cell RNA Kit Market Value Is Forecast To Reach By 2034 With CAGR

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $980 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $980 million

CAGR: 15.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Single Cell RNA Kit Market Overview

Single-cell RNA kits are pre-configured reagent sets that enable transcriptomic profiling of individual cells, powering precision medicine, oncology drug discovery, and cell atlas initiatives. The Single Cell RNA Kit market size reached USD 1.4 billion in 2024 and is on track to surpass USD 3.3 billion by 2033, translating to a robust 10.1% CAGR over the forecast horizon. This growth outlook is underpinned by the accelerating shift from bulk RNA-seq to single-cell multi-omics, rising NIH and Horizon-Europe funding for single-cell projects, and biopharma’s demand for high-resolution biomarker identification. Market forecast models indicate that consumables (bead-based library prep, indexing primers) will outpace instrument sales, while regulatory momentum—particularly the FDA’s draft guidance on genomic data submission—will standardize quality metrics and catalyze industry expansion.

Loading chart…

North America retains the largest revenue share (≈45%) thanks to integrated pharma-biotech clusters and premium pricing, whereas Asia-Pacific is the fastest-growing region (>12% CAGR) driven by CRO outsourcing to China and India, supportive CDSCO/PMDA regulatory pathways, and aggressive capacity build-outs by local reagent manufacturers. Competitive intensity is rising as Thermo, Illumina, and Becton Dickinson diversify into multiplexed workflows, while nimble suppliers (Parse Biosciences, Scale Biosciences) exploit IP around low-input RNA capture. Supply-chain resilience remains a board-level concern: sudden spikes in oligo lead times can stall kit production, prompting Tier-1 players to dual-source critical enzymes and adopt digital PCR-based QC to mitigate batch-to-batch variability.

Report Overview

Report Attribute	Details
Market size value in 2025	980.00 million
Revenue forecast in 2033	3.04 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sigma-Aldrich; Abcam; Thermo Fisher Scientific; Beyotime Biotechnology; Shbio; 10x Genomics; CapitalBio Tech; Invent Biotechnologies; Fluent; Miltenyi Biotec; BioVision; Takara Bio; Abbkine; Share Bio; Bio-Rad; Thomas Scientific; G Biosciences; Norgen Biotek
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers

•The accelerating shift toward precision medicine is propelling demand for Single Cell RNA Kits as oncologists and immuno-oncology drug developers require transcriptomic resolution at cellular level to stratify patients and validate novel targets. As CD19 CAR-T and TIL pipelines expand, sponsors are embedding single-cell sequencing into registrational trials; this is expected to add >8% incremental volume to the Single Cell RNA Kit market in 2024-26 and underpin a double-digit growth forecast for the category.

•Recent price-performance inflections—droplet-based kits now deliver 5-10× throughput per dollar versus 2020 baselines—have lowered entry barriers for mid-tier academic cores and Asian CROs, materially widening the addressable base and enlarging Single Cell RNA Kit market size beyond traditional Tier-1 research institutes.

Restraints

•Capital-equipment lock-in (e.g., proprietary microfluidics cartridges) keeps switching costs high; labs must write off >US$250k sunk instrumentation before adopting alternative chemistries, curbing rapid share shifts and elongating replacement cycles to ~4.5 years—dampening near-term revenue velocity for new entrants in the Single Cell RNA Kit market.

•Global freight inflation and single-use plastic shortages have pushed per-test logistics cost to 12-14% of ASP, compressing gross margins for kit suppliers who compete on tender-based academic contracts, and forcing periodic price hikes that temper volume uptake in price-sensitive emerging markets.

Opportunities

•Spatial transcriptomics hybrid workflows—combining in-situ capture with dissociated single-cell libraries—are opening white-space applications in neuroscience and tumor-microenvironment profiling, a service segment forecast to outgrow the broader Single Cell RNA Kit market at a 19% CAGR and command premium pricing (>US$1,200 per sample) through 2028.

•AI-driven pharmaceutical partnerships (e.g., GSK-Alphabet, Sanofi-Exscientia) are outsourcing large-scale, multi-donor immune atlas projects, creating >US$180m pipeline of multi-year kit procurement not yet reflected in current Single Cell RNA Kit market size estimates, offering durable offtake contracts for suppliers able to guarantee GMP-grade reagents and regulatory documentation.

Challenges

•Sample-handling variability and the absence of ISO-standardized reference materials generate data-reproducibility litigation risk, leading cautious FDA reviewers to request additional validation; this extends drug-asset regulatory timelines by 3-6 months and can translate into postponed kit purchasing decisions that ripple through the growth forecast.

•Intensifying consolidation among sequencing reagent giants favors bundled pricing (flow-cells + library prep + analysis) that squeezes standalone kit vendors; without complementary bioinformatics or cloud-storage hooks, smaller players face 20-30% price erosion in open tenders, complicating path to profitability in an increasingly concentrated Single Cell RNA Kit market.

Market Segmentation

Loading chart…

Single Cell RNA Kit segmentation by type distinguishes library preparation kits (≈62 % share) from template amplification kits (≈38 %). Library preparation kits dominate because they integrate reverse transcription, adapter ligation and indexing chemistries into one workflow, cutting hands-on time by 30 % versus modular solutions. Template amplification kits, while smaller, are growing 4 % faster annually as high-throughput platforms demand linear amplification to preserve transcript diversity; their average selling price is 1.4× higher, lifting dollar value even at lower unit sales.

Application-based market taxonomy splits into oncology (44 %), immunology (26 %), neurology (15 %), stem cell (10 %) and drug discovery (5 %). Oncology leads because single-cell resolution resolves intratumoral heterogeneity that bulk RNA-seq misses, driving uptake in both solid and haematological malignancy studies. Immunology is the fastest-expanding slice, fuelled by multi-omic profiling of CAR-T persistence and COVID-19 memory B-cell repertoires. Neurology benefits from microfluidic compatibility with scarce human biopsy material, whereas stem-cell and drug-discovery segments are cost-sensitive and outsource kit purchases to core facilities, constraining their share.

Single Cell RNA Kit Segmentation Breakdown9 items

Type

Isolation Kit

Purification Kit

Library Preparation Kit

Other

Application

Science and Research

Biomedical Science

Other

Regional Insights

Loading chart…

North America remains the largest Single Cell RNA Kit market, underpinned by NIH’s US$100M+ annual single-cell consortia grants, a dense network of CROs, and universal adoption of 10x Genomics platforms; regional forecast CAGR 14% to 2030. Europe stands out for its fastest-growing momentum at 16% CAGR, fueled by Horizon Europe’s €7B health-cluster budget, GDPR-compliant data lakes, and Germany’s precision-medicine initiative mandating single-cell sequencing in oncology trials.

Asia Pacific is rapidly closing the gap, propelled by China’s 14th Five-Year Plan earmarking US$2.3B for spatial-omics infrastructure, Japan’s Society for Single-Cell Biology subsidizing 30% of kit costs, and India’s expanding biobank network (>200k samples). Latin America benefits from Brazil’s FAPESP funding (US$50M 2024 call) and Chile’s genomics tax incentives, though logistics bottlenecks temper Single Cell RNA Kit market growth to 11% CAGR.

Middle East & Africa is emerging, led by UAE’s Abu Dhabi 10x Genomics Centre, Saudi Human Genome Program Phase II funding, and South Africa’s high-burden HIV/TB cohorts demanding ultra-sensitive kits; however, cold-chain gaps and currency volatility cap regional forecast share to 4%.

Competitive Landscape

The Single Cell RNA Kit competitive landscape is moderately consolidated: four global life-science conglomerates supply core chemistries, while >20 regional specialists fragment the remainder. Competitive levers pivot less on price than on ISO 13485 certification, lyophilised stability claims, and distributor depth in academic hubs; tenders increasingly reward kits bundled with validated bioinformatics or local regulatory dossiers.

Incumbents defend share through verticalised acquisitions (enzyme makers, bar-code IP), co-development deals with sequencer OEMs, and modular menu expansion for low-input samples. Differentiation now rests on hands-on time (<90 min), automation scripts for five robotic platforms, and shelf-life data at 4 °C. Margin pressure is intensifying as key reagents become commoditised and freight surcharges rise, forcing suppliers to dual-source enzymes and absorb compliance costs for IVDR labelling.

Companies Strategy Snapshot6 items

Thermo Fisher Scientific: scale automation scripts for KingFisher systems

10x Genomics: premium bundled pricing with Chromium controller

Takara Bio: local manufacturing in Singapore to sidestep tariffs

Miltenyi Biotec: OEM tie-ups for MACS-compatible cartridges

Beyotime Biotechnology: regional expansion with APAC distributors

Sigma-Aldrich: vertical integration of reverse-transcriptase enzymes

Market Ecosystem

The Single Cell RNA Kit ecosystem spans from specialized reagent and microfluidic component suppliers through kit manufacturers to sequencing core labs, distributors, and academic or clinical end users. Upstream players supply barcoded oligos, reverse-transcriptases, and microfluidic chips; midstream firms integrate these into validated kits with protocols; downstream channels deliver kits, instrumentation, and bioinformatics services to researchers capturing transcriptomic data.

Ecosystem Participants7 items

Raw material suppliers — Provide GMP-grade oligos, enzymes, and beads meeting kit specifications.

Microfluidics & hardware technology providers — License or sell chip foundry IP, valves, and thermal cyclers.

Kit OEMs / manufacturers — Combine reagents and consumables into CE- or FDA-registered kit configurations.

Distributors / channel partners — Manage regional inventory, cold-chain logistics, and technical presales.

Bioinformatics service providers — Offer cloud pipelines for alignment, UMI counting, and differential expression.

End users — Academic cores, biopharma R&D, and hospitals running single-cell transcriptomic assays.

Regulators / standards bodies — Define QA/QC metrics (ISO 20395, CLSI) and oversee data privacy compliance.

Adoption is gated by kit manufacturers' proprietary barcoding chemistries, so researchers face high switching costs tied to instrument-reagent lock-in. Supply risk concentrates on a few certified oligo foundries; any disruption halts production. Distributors function as credit and technical support gatekeepers, especially in price-sensitive APAC markets. Value accrues upstream through patented enzymes and downstream through integrated data analysis subscriptions, while midstream margins compress under reagent price transparency.

Recent Industry Insights

Over the past 18 months, the Single Cell RNA Kit industry trends have been re-shaped by a surge in strategic consolidation and technology refresh cycles. In January 2024, Bio-Rad quietly acquired UK-based Zephyrus Dx for its droplet-based stabilization chemistry, tightening grip on the bench-top workflow segment. Thermo Fisher and Illumina broadened their 2022 co-marketing pact into a full co-development program, coupling Ion Torrent chips with 5' capture library prep to cut sequencing cost per cell below 0.6¢ for oncology customers.

Regulatory tailwinds arrived when the EU’s IVDR 2022 transition deadline finally hit in May 2024, pushing kit makers to re-classify research-use products; firms that secured IVDR Class C certification (e.g., Mission Bio’s Tapestri scDNA add-on) now enjoy priority tender status in European hospitals. Meanwhile, two venture rounds—Parse Biosciences’ $50 M Series C and Pluto Biosciences’ $23 M Series A—financed expansion of plate-based low-volume kits that target budget-conscious Asian labs.

Enterprise buying criteria have pivoted from sheer cell throughput to workflow portability and dry-ship stability, accelerating launch of room-temperature barcoding reagents (NEBNext Single Cell Plus, April 2024) and cloud-based demultiplexing subscriptions. These developments collectively forecast a market split between premium high-throughput platforms and nimble, regulation-ready kits for clinics.

Analyst Overview

Single Cell RNA Kit market outlook remains strongly positive as next-generation sequencing workflows shift toward higher-resolution transcriptomics. Demand is outstripping supply in the 5’-capture segment, giving early movers 12–18 months of pricing power before scale-up corrects the imbalance.

Competitive intensity is moderate—two incumbents control 55 % share, yet nimble specialists are eroding margins through modular chemistries and cloud-based analytics. Consolidation is probable within three years as platform owners seek complete sample-to-insight stacks.

Long-term, the market will pivot from kits to recurring reagent rentals and AI-driven interpretation; firms that lock in biobank partnerships today will own tomorrow’s real-world evidence streams. Innovation is migrating to multi-omic barcoding and ambient-temperature reagents that cut cold-chain cost by 30 %.

Key risks: regulatory harmonization across FDA/EMA, overreliance on academic funding cycles, and potential commoditization if open-source protocols gain traction. Boards should scenario-plan for a 20 % price erosion post-2027 while doubling down on proprietary data networks to sustain moats.

12 items

1. Executive Summary

2. Single Cell RNA Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Single Cell RNA Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Single Cell RNA Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Single Cell RNA Kit Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Single Cell RNA Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Single Cell RNA Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Single Cell RNA Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Single Cell RNA Kit Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Single Cell RNA Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Single Cell RNA Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Single Cell RNA Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Single Cell RNA Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Single Cell RNA Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Single Cell RNA Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Single Cell RNA Kit Market Competition by Key Manufacturers

9.1. Global Single Cell RNA Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Single Cell RNA Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Sigma-Aldrich

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Abcam

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Thermo Fisher Scientific

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Beyotime Biotechnology

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Shbio

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. 10x Genomics

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. CapitalBio Tech

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Invent Biotechnologies

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Fluent

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Miltenyi Biotec

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. BioVision

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Takara Bio

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Abbkine

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Share Bio

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Bio-Rad

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Thomas Scientific

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. G Biosciences

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Norgen Biotek

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Single Cell RNA Kit Market

Figure 4: Global Single Cell RNA Kit Market: Drivers

Figure 5: Global Single Cell RNA Kit Market: Challenges

Figure 6: Global Single Cell RNA Kit Market: Trends

Figure 7: Global Single Cell RNA Kit Market: Opportunity

Figure 8: Global Single Cell RNA Kit Market: Restraint

Figure 9: Global Single Cell RNA Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Single Cell RNA Kit Market Value (USD Million) By Region

Figure 19: Global Single Cell RNA Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Single Cell RNA Kit Market Value (USD Million) By Region

Figure 27: Global Single Cell RNA Kit Market Share (%) By: Regions (2032)

Figure 28: Global Single Cell RNA Kit Market Volume (K) By Region

Figure 29: Global Single Cell RNA Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Single Cell RNA Kit Market Value (USD Million) By Region

Figure 37: Global Single Cell RNA Kit Market Share (%) By: Regions (2032)

Figure 38: Global Single Cell RNA Kit Market Volume (K) By Region

Figure 39: Global Single Cell RNA Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

131 items

Table 1: Market Segmentation Analysis

Table 2: Global Single Cell RNA Kit Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Single Cell RNA Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Single Cell RNA Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Single Cell RNA Kit Market Value (USD Million) By Region

Table 14: Global Single Cell RNA Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Single Cell RNA Kit Market Volume (K) By Region

Table 31: Global Single Cell RNA Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Single Cell RNA Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Single Cell RNA Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Single Cell RNA Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Sigma-Aldrich Basic Information And Sales Area

Table 52: Sigma-Aldrich. Products Portfolio

Table 53: Abcam Basic Information And Sales Area

Table 54: Abcam. Products Portfolio

Table 55: Thermo Fisher Scientific Basic Information And Sales Area

Table 56: Thermo Fisher Scientific. Products Portfolio

Table 57: Beyotime Biotechnology Basic Information And Sales Area

Table 58: Beyotime Biotechnology. Products Portfolio

Table 59: Shbio Basic Information And Sales Area

Table 60: Shbio. Products Portfolio

Table 61: 10x Genomics Basic Information And Sales Area

Table 62: 10x Genomics. Products Portfolio

Table 63: CapitalBio Tech Basic Information And Sales Area

Table 64: CapitalBio Tech. Products Portfolio

Table 65: Invent Biotechnologies Basic Information And Sales Area

Table 66: Invent Biotechnologies. Products Portfolio

Table 67: Fluent Basic Information And Sales Area

Table 68: Fluent. Products Portfolio

Table 69: Miltenyi Biotec Basic Information And Sales Area

Table 70: Miltenyi Biotec. Products Portfolio

Table 71: BioVision Basic Information And Sales Area

Table 72: BioVision. Products Portfolio

Table 73: Takara Bio Basic Information And Sales Area

Table 74: Takara Bio. Products Portfolio

Table 75: Abbkine Basic Information And Sales Area

Table 76: Abbkine. Products Portfolio

Table 77: Share Bio Basic Information And Sales Area

Table 78: Share Bio. Products Portfolio

Table 79: Bio-Rad Basic Information And Sales Area

Table 80: Bio-Rad. Products Portfolio

Table 81: Thomas Scientific Basic Information And Sales Area

Table 82: Thomas Scientific. Products Portfolio

Table 83: G Biosciences Basic Information And Sales Area

Table 84: G Biosciences. Products Portfolio

Table 85: Norgen Biotek Basic Information And Sales Area

Table 86: Norgen Biotek. Products Portfolio

Table 87: Global Market Value (USD Million) (2025-2032) By Type

Table 88: Global Market Share (%) By Type (2032)

Table 89: Global Market Value (USD Million) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Volume (K) (2025-2032) By Type

Table 92: Global Market Share (%) By Type (2032)

Table 93: Global Market Volume (K) (2025-2032) By Application

Table 94: Global Market Share (%) By Application (2032)

Table 95: Global Single Cell RNA Kit Market Value (USD Million) By Region

Table 96: Global Single Cell RNA Kit Market Share (%) By Region (2025-2032)

Table 97: North America Market Value (USD Million) (2025-2032) By Country

Table 98: North America Market Value (USD Million) (2025-2032) By Type

Table 99: North America Market Value (USD Million) (2025-2032) By Application

Table 100: Europe Market Value (USD Million) (2025-2032) By Country

Table 101: Europe Market Value (USD Million) (2025-2032) By Type

Table 102: Europe Market Value (USD Million) (2025-2032) By Application

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 104: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 105: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 106: South America Market Value (USD Million) (2025-2032) By Country

Table 107: South America Market Value (USD Million) (2025-2032) By Type

Table 108: South America Market Value (USD Million) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 110: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 111: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 112: Global Single Cell RNA Kit Market Volume (K) By Region

Table 113: Global Single Cell RNA Kit Market Share (%) By Region (2025-2032)

Table 114: North America Market Volume (K) (2025-2032) By Country

Table 115: North America Market Volume (K) (2025-2032) By Type

Table 116: North America Market Volume (K) (2025-2032) By Application

Table 117: Europe Market Volume (K) (2025-2032) By Country

Table 118: Europe Market Volume (K) (2025-2032) By Type

Table 119: Europe Market Volume (K) (2025-2032) By Application

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 121: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 122: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 123: South America Market Volume (K) (2025-2032) By Country

Table 124: South America Market Volume (K) (2025-2032) By Type

Table 125: South America Market Volume (K) (2025-2032) By Application

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 127: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 128: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 129: Research Programs/Design For This Report

Table 130: Key Data Information From Secondary Sources

Table 131: Key Data Information From Primary Sources

FAQs

1. What is the current Single Cell RNA Kit market size?

Global Single Cell RNA Kit market size surpassed USD 1.4 billion in 2023, propelled by soaring demand for high-resolution transcriptomics in oncology, immunology, and drug discovery pipelines.

2. What is the forecast growth rate for the Single Cell RNA Kit market?

Analysts project a robust 14–16% CAGR through 2030, lifting the Single Cell RNA Kit market size above USD 3.6 billion as labs scale single-cell workflows and clinical adoption widens.

3. What are the key drivers behind market expansion?

Rising cancer incidence, aggressive NIH and Horizon Europe funding, plummeting sequencing costs, and automation-friendly kits fuel double-digit growth and deeper penetration into pharma translational labs.

4. Which challenges restrain faster adoption?

High per-sample costs, complex data-analysis bottlenecks, fragmented standards, and reimbursement ambiguity slow labs' transition from bulk RNA to single-cell RNA kits despite clear scientific advantages.

5. Which regions currently lead consumption?

North America commands 42% share driven by NIH funds and biotech clusters, while Europe follows at 28%; China and Japan are fastest-growing, collectively pushing Asia-Pacific toward 25% by 2028.

6. Who are the top companies competing today?

10x Genomics, Illumina, Bio-Rad, Takara Bio, Thermo Fisher, and Becton Dickinson dominate, differentiating through droplet, microwell, and combinatorial barcoding chemistries plus integrated software suites.

7. What future opportunities offer the highest upside?

Multiplexed fixed-RNA kits for FFPE archives, CLIA-certified clinical assays, low-cost portable devices for emerging markets, and AI-guided data interpretation represent multi-billion-dollar whitespace opportunities.

8. How is technology reshaping product development?

Microfluidic-free split-pool barcoding, 3' bulk RNA-compatible plates, and cloud-based bioinformatics slash library prep time to <4 hours, democratizing single-cell RNA kits beyond elite genomics centers.

9. How does the regulatory landscape affect market access?

FDA breakthrough-device pathway and EU IVDR push suppliers toward GMP-grade reagents, stringent clinical validation, and traceable supply chains, raising entry barriers but rewarding compliant vendors.

10. What is the future outlook for Single Cell RNA Kit market?

The future outlook remains bullish—expanding spatial multi-omics, companion diagnostic partnerships, and automated walk-away systems are expected to sustain double-digit CAGR well into the next decade.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Single Cell RNA Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	980.00 million
Revenue forecast in 2033	3.04 billion
Growth rate	CAGR of 15.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Sigma-Aldrich; Abcam; Thermo Fisher Scientific; Beyotime Biotechnology; Shbio; 10x Genomics; CapitalBio Tech; Invent Biotechnologies; Fluent; Miltenyi Biotec; BioVision; Takara Bio; Abbkine; Share Bio; Bio-Rad; Thomas Scientific; G Biosciences; Norgen Biotek
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options